For the quarter ending 2025-10-31, CSBR had -$1,809K decrease in cash & cash equivalents over the period. -$1,977K in free cash flow.
| Cash Flow | 2025-10-31 | 2025-07-31 |
|---|---|---|
| Net (loss) income | 236 | -466 |
| Stock-based compensation | 249 | 208 |
| Depreciation and amortization expense | 357 | 358 |
| Loss on disposal of equipment | 0 | -20 |
| Gain on termination of operating lease | 9 | - |
| Operating lease right-of use assets | 424 | 310 |
| Allowance and estimated credit losses | 13 | -29 |
| Accounts receivable | 2,078 | -1,759 |
| Prepaid expenses and other current assets | 62 | -154 |
| Accounts payable | 1,311 | 411 |
| Accrued liabilities | 388 | -755 |
| Operating lease liabilities | -473 | -356 |
| Deferred revenue | -2,091 | -1,014 |
| Net cash (used in) provided by operating activities | -1,735 | 600 |
| Purchase of property and equipment | 242 | 46 |
| Net cash used in investing activities | -242 | -46 |
| Proceeds from exercise of options | 207 | 24 |
| Finance lease payments | 39 | 38 |
| Net cash provided by financing activities | 168 | -14 |
| (decrease) increase in cash | -1,809 | 540 |
| Cash and cash equivalents at beginning of period | 9,785 | - |
| Cash and cash equivalents at end of period | 8,516 | - |
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)